{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:05:32Z","timestamp":1782878732996,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001704","name":"European Society of Clinical Microbiology and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cmi.2020.07.001","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T19:19:46Z","timestamp":1594322386000},"page":"736-741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off values"],"prefix":"10.1016","volume":"27","author":[{"given":"O.","family":"Karatuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.B.","family":"Dance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Matuschek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"\u00c5hman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Amornchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Wuthiekanun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.-P.","family":"Cusack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hennessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zoeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Grunow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kahlmeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.07.001_bib1","doi-asserted-by":"crossref","first-page":"17107","DOI":"10.1038\/nrdp.2017.107","article-title":"Melioidosis","volume":"4","author":"Wiersinga","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cmi.2020.07.001_bib2","doi-asserted-by":"crossref","first-page":"15008","DOI":"10.1038\/nmicrobiol.2015.8","article-title":"Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis","volume":"1","author":"Limmathurotsakul","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.cmi.2020.07.001_bib3","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/infdis\/159.5.890","article-title":"Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand","volume":"159","author":"Chaowagul","year":"1989","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2020.07.001_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijantimicag.2014.01.005","article-title":"Treatment and prophylaxis of melioidosis","volume":"43","author":"Dance","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2020.07.001_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0034-1398389","article-title":"Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment","volume":"36","author":"Currie","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2020.07.001_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.qco.0000244046.31135.b3","article-title":"Melioidosis","volume":"19","author":"Peacock","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2020.07.001_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drup.2016.07.003","article-title":"Antibiotic resistance in Burkholderia species","volume":"28","author":"Rhodes","year":"2016","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.cmi.2020.07.001_bib8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1086\/444456","article-title":"Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis","volume":"41","author":"Chierakul","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2020.07.001_bib9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jama.1946.02870160009004","article-title":"Melioidosis on Guam","volume":"130","author":"Mirick","year":"1946","journal-title":"J\u00a0Am Med Assoc"},{"issue":"Supplement 3","key":"10.1016\/j.cmi.2020.07.001_bib10","doi-asserted-by":"crossref","first-page":"S539","DOI":"10.1093\/infdis\/128.Supplement_3.S539","article-title":"In\u00a0vitro sensitivity of 33 strains of Pseudomonas pseudomallei to trimethoprim and sulfamethoxazole","volume":"128","author":"Everett","year":"1973","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2020.07.001_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/jac\/20.6.921","article-title":"Antimicrobial susceptibility of Pseudomonas pseudomallei","volume":"20","author":"Puthucheary","year":"1987","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.07.001_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/24.3.295","article-title":"The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment","volume":"24","author":"Dance","year":"1989","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.07.001_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0924-8579(00)00334-4","article-title":"Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis","volume":"17","author":"Jenney","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2020.07.001_bib14","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jac\/dkh471","article-title":"Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents","volume":"54","author":"Thibault","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.07.001_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jgar.2019.01.024","article-title":"Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam","volume":"18","author":"Nhung","year":"2019","journal-title":"J\u00a0Glob Antimicrob Resist"},{"key":"10.1016\/j.cmi.2020.07.001_bib16","series-title":"Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. 3rd ed. CLSI guideline M45","year":"2016"},{"key":"10.1016\/j.cmi.2020.07.001_bib17","year":"2019"},{"key":"10.1016\/j.cmi.2020.07.001_bib18","doi-asserted-by":"crossref","first-page":"O255","DOI":"10.1111\/1469-0691.12373","article-title":"Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories","volume":"20","author":"Matuschek","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2020.07.001_bib20","article-title":"MIC distributions and epidemiological cut-off value (ECOFF) setting","year":"2019","journal-title":"EUCAST SOP 10.1"},{"key":"10.1016\/j.cmi.2020.07.001_bib22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(89)90768-X","article-title":"Halving of mortality of severe melioidosis by ceftazidime","volume":"2","author":"White","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2020.07.001_bib23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/clinids\/19.5.846","article-title":"Ceftazidime vs. amoxicillin\/clavulanate in the treatment of severe melioidosis","volume":"19","author":"Suputtamongkol","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2020.07.001_bib24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(13)61951-0","article-title":"Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial","volume":"383","author":"Chetchotisakd","year":"2014","journal-title":"Lancet"},{"issue":"Suppl 4","key":"10.1016\/j.cmi.2020.07.001_bib25","first-page":"S46","article-title":"Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility","volume":"92","author":"Paveenkittiporn","year":"2009","journal-title":"J\u00a0Med Assoc Thai"},{"key":"10.1016\/j.cmi.2020.07.001_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/mdr.2019.0260","article-title":"Correlation between Etest and reference broth microdilution for antimicrobial susceptibility testing of Burkholderia pseudomallei","volume":"26","author":"Lonsway","year":"2020","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.cmi.2020.07.001_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijantimicag.2014.06.003","article-title":"Trimethoprim\/sulfamethoxazole resistance in Burkholderia pseudomallei","volume":"44","author":"Dance","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2020.07.001_bib28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ijantimicag.2015.01.006","article-title":"Trimethoprim\/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand","volume":"45","author":"Saiprom","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2020.07.001_bib29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/jac\/dki151","article-title":"Trimethoprim\/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei","volume":"55","author":"Wuthiekanun","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.07.001_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jgar.2017.04.012","article-title":"Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from northern Queensland to meropenem, ceftazidime, trimethoprim\/sulfamethoxazole and doxycycline by the microbroth dilution method","volume":"10","author":"Maloney","year":"2017","journal-title":"J\u00a0Glob Antimicrob Resist"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20303840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20303840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:29:04Z","timestamp":1761118144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X20303840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1198743X20303840"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.07.001","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off values","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}